eValueDrugs is a privately held Swiss company founded by professionals with broad experience in the drug development process. Working with world-class partners and advisors from the executive ranks of leading pharmaceuticals companies, we deliver complete solutions that dramatically shorten the drug development cycle and provide substantial cost reductions.

eValueDrugs capitalizes on today's innovative IT tools and systems to connect all services providers with the bio-pharmaceutical companies, thus orchestrating and offering a seamless data & information flow to the end users in the bio-pharmaceutical industry leading to significant reductions in time & cost within the overall drug development process.

As a result bio-pharmaceutical companies will be in a position to deliver more drugs to the market faster through selecting the more promising compounds earlier in the drug development process with a better ROI.